LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged examination · clear

Federal Circuit

Semicolons Strongly Indicate Each Step is Separate and Distinct; Confuse Most Non-Patent Lawyers

In In re Affinity Labs of Texas, LLC, [2016-1173] (May 5, 2017), the Federal Circuit affirmed the Board’s decision that §317(b) did not bar the reexamination and that the reexamined claims were invalid. Affinity sued Apple for infringement of…

May 11, 2017·Federal Circuit·2 min read
USPTO Policy

The Play and Pause for Uspto S Track One April 2011 Update

In the first week of April 2011, the USPTO fused life into the much-awaited system of allowing prioritized and expedited examination of patent applications. On 4 th April, 2011, the USPTO announced its plans to begin accepting requests for fast-track or…

April 27, 2011·USPTO Policy·5 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.